NCT02766855View on ClinicalTrials.gov

Efficacy of Topical Cysteamine in Nephropathic Cyctinosis

NACompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

December 31, 2012

Study Completion Date

March 31, 2016

Conditions
Nephropathic CyctinosisCorneal Cystine Crystals
Interventions
DRUG

Cysteamine

Patients were asked to use topical cysteamine 0.55% eye drops every 2 hours while awake to both eyes.

All Listed Sponsors
lead

The Eye Center and The Eye Foundation for Research in Ophthalmology

OTHER

NCT02766855 - Efficacy of Topical Cysteamine in Nephropathic Cyctinosis | Biotech Hunter | Biotech Hunter